| ■ 영문 제목 : Global Sorafenib Tosylate Tablets Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02189 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 90 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 소라페닙 토실레이트 정제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (60개/Box, 120개/Box, 기타)와 용도별 시장규모 (병원, 온라인 판매, 약국, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 소라페닙 토실레이트 정제 시장 점유율 - 지역별 소라페닙 토실레이트 정제 시장규모 - 주요지역의 종류별 시장규모 (60개/Box, 120개/Box, 기타) - 주요지역의 용도별 시장규모 (병원, 온라인 판매, 약국, 기타) - 미주의 소라페닙 토실레이트 정제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 소라페닙 토실레이트 정제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 소라페닙 토실레이트 정제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 소라페닙 토실레이트 정제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 소라페닙 토실레이트 정제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd., Chongqing Yaoyou Pharmaceutical Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Sorafenib Tosylate Tablets will have significant change from previous year. By the most conservative estimates of global Sorafenib Tosylate Tablets market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Sorafenib Tosylate Tablets market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Sorafenib Tosylate Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
60 Pieces/Box
120 Pieces/Box
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Online Sale
Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bayer
Cipla
Beijing Yabao Biological Pharmaceutical Co., Ltd.
Chongqing Yaoyou Pharmaceutical Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.
1 Scope of the Report 2 Executive Summary 3 Global Sorafenib Tosylate Tablets by Company 4 Sorafenib Tosylate Tablets by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Sorafenib Tosylate Tablets Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Sorafenib Tosylate Tablets Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 60 Pieces/Box Table 3. Major Players of 120 Pieces/Box Table 4. Major Players of Others Table 5. Global Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units) Table 6. Global Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2021) Table 7. Global Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & ($ million) Table 8. Global Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2021) Table 9. Global Sorafenib Tosylate Tablets Sale Price by Type (2016-2021) Table 10. Global Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units) Table 11. Global Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2021) Table 12. Global Sorafenib Tosylate Tablets Value by Application (2016-2021) Table 13. Global Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2021) Table 14. Global Sorafenib Tosylate Tablets Sale Price by Application (2016-2021) Table 15. Global Sorafenib Tosylate Tablets Sales by Company (2019-2021) & (K Units) Table 16. Global Sorafenib Tosylate Tablets Sales Market Share by Company (2019-2021) Table 17. Global Sorafenib Tosylate Tablets Revenue by Company (2019-2021) ($ Millions) Table 18. Global Sorafenib Tosylate Tablets Revenue Market Share by Company (2019-2021) Table 19. Global Sorafenib Tosylate Tablets Sale Price by Company (2019-2021) Table 20. Key Manufacturers Sorafenib Tosylate Tablets Producing Area Distribution and Sales Area Table 21. Players Sorafenib Tosylate Tablets Products Offered Table 22. Sorafenib Tosylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Sorafenib Tosylate Tablets Sales by Region (2016-2021) (K Units) Table 26. Global Sorafenib Tosylate Tablets Sales Market Share by Region (2016-2021) Table 27. Global Sorafenib Tosylate Tablets Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Sorafenib Tosylate Tablets Revenue Market Share by Region (2016-2021) Table 29. Americas Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units) Table 30. Americas Sorafenib Tosylate Tablets Sales Market Share by Country (2016-2021) Table 31. Americas Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Sorafenib Tosylate Tablets Revenue Market Share by Country (2016-2021) Table 33. Americas Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units) Table 34. Americas Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2021) Table 35. Americas Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units) Table 36. Americas Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2021) Table 37. APAC Sorafenib Tosylate Tablets Sales by Region (2016-2021) & (K Units) Table 38. APAC Sorafenib Tosylate Tablets Sales Market Share by Region (2016-2021) Table 39. APAC Sorafenib Tosylate Tablets Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Sorafenib Tosylate Tablets Revenue Market Share by Region (2016-2021) Table 41. APAC Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units) Table 42. APAC Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2021) Table 43. APAC Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units) Table 44. APAC Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2021) Table 45. Europe Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units) Table 46. Europe Sorafenib Tosylate Tablets Sales Market Share by Country (2016-2021) Table 47. Europe Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Sorafenib Tosylate Tablets Revenue Market Share by Country (2016-2021) Table 49. Europe Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units) Table 50. Europe Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2021) Table 51. Europe Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units) Table 52. Europe Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units) Table 54. Middle East & Africa Sorafenib Tosylate Tablets Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Sorafenib Tosylate Tablets Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units) Table 58. Middle East & Africa Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units) Table 60. Middle East & Africa Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of Sorafenib Tosylate Tablets Table 62. Key Application and Potential Industries of Sorafenib Tosylate Tablets Table 63. Key Challenges of Sorafenib Tosylate Tablets Table 64. Key Trends of Sorafenib Tosylate Tablets Table 65. Sorafenib Tosylate Tablets Distributors List Table 66. Sorafenib Tosylate Tablets Customer List Table 67. Global Sorafenib Tosylate Tablets Sales Forecast by Region (2021-2026) & (K Units) Table 68. Global Sorafenib Tosylate Tablets Consumption Market Forecast by Region Table 69. Global Sorafenib Tosylate Tablets Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Sorafenib Tosylate Tablets Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Sorafenib Tosylate Tablets Sales Forecast by Country (2021-2026) & (K Units) Table 72. Americas Sorafenib Tosylate Tablets Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Sorafenib Tosylate Tablets Sales Forecast by Region (2021-2026) & (K Units) Table 74. APAC Sorafenib Tosylate Tablets Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Sorafenib Tosylate Tablets Sales Forecast by Country (2021-2026) & (K Units) Table 76. Europe Sorafenib Tosylate Tablets Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Sorafenib Tosylate Tablets Sales Forecast by Country (2021-2026) & (K Units) Table 78. Middle East & Africa Sorafenib Tosylate Tablets Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Sorafenib Tosylate Tablets Sales Forecast by Type (2021-2026) & (K Units) Table 80. Global Sorafenib Tosylate Tablets Sales Market Share Forecast by Type (2021-2026) Table 81. Global Sorafenib Tosylate Tablets Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global Sorafenib Tosylate Tablets Revenue Market Share Forecast by Type (2021-2026) Table 83. Global Sorafenib Tosylate Tablets Sales Forecast by Application (2021-2026) & (K Units) Table 84. Global Sorafenib Tosylate Tablets Sales Market Share Forecast by Application (2021-2026) Table 85. Global Sorafenib Tosylate Tablets Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global Sorafenib Tosylate Tablets Revenue Market Share Forecast by Application (2021-2026) Table 87. Bayer Basic Information, Sorafenib Tosylate Tablets Manufacturing Base, Sales Area and Its Competitors Table 88. Bayer Sorafenib Tosylate Tablets Product Offered Table 89. Bayer Sorafenib Tosylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 90. Bayer Main Business Table 91. Bayer Latest Developments Table 92. Cipla Basic Information, Sorafenib Tosylate Tablets Manufacturing Base, Sales Area and Its Competitors Table 93. Cipla Sorafenib Tosylate Tablets Product Offered Table 94. Cipla Sorafenib Tosylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 95. Cipla Main Business Table 96. Cipla Latest Developments Table 97. Beijing Yabao Biological Pharmaceutical Co., Ltd. Basic Information, Sorafenib Tosylate Tablets Manufacturing Base, Sales Area and Its Competitors Table 98. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Offered Table 99. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 100. Beijing Yabao Biological Pharmaceutical Co., Ltd. Main Business Table 101. Beijing Yabao Biological Pharmaceutical Co., Ltd. Latest Developments Table 102. Chongqing Yaoyou Pharmaceutical Co., Ltd. Basic Information, Sorafenib Tosylate Tablets Manufacturing Base, Sales Area and Its Competitors Table 103. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Offered Table 104. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 105. Chongqing Yaoyou Pharmaceutical Co., Ltd. Main Business Table 106. Chongqing Yaoyou Pharmaceutical Co., Ltd. Latest Developments Table 107. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Basic Information, Sorafenib Tosylate Tablets Manufacturing Base, Sales Area and Its Competitors Table 108. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Offered Table 109. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 110. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Main Business Table 111. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Latest Developments Table 112. CSPC Ouyi Pharmaceutical Co., Ltd. Basic Information, Sorafenib Tosylate Tablets Manufacturing Base, Sales Area and Its Competitors Table 113. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Offered Table 114. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 115. CSPC Ouyi Pharmaceutical Co., Ltd. Main Business Table 116. CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments List of Figures Figure 1. Picture of Sorafenib Tosylate Tablets Figure 2. Sorafenib Tosylate Tablets Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Sorafenib Tosylate Tablets Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Sorafenib Tosylate Tablets Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Sorafenib Tosylate Tablets Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 60 Pieces/Box Figure 10. Product Picture of 120 Pieces/Box Figure 11. Product Picture of Others Figure 12. Global Sorafenib Tosylate Tablets Sales Market Share by Type in 2020 Figure 13. Global Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2021) Figure 14. Sorafenib Tosylate Tablets Consumed in Hospital Figure 15. Global Sorafenib Tosylate Tablets Market: Hospital (2016-2021) & (K Units) Figure 16. Sorafenib Tosylate Tablets Consumed in Online Sale Figure 17. Global Sorafenib Tosylate Tablets Market: Online Sale (2016-2021) & (K Units) Figure 18. Sorafenib Tosylate Tablets Consumed in Pharmacy Figure 19. Global Sorafenib Tosylate Tablets Market: Pharmacy (2016-2021) & (K Units) Figure 20. Sorafenib Tosylate Tablets Consumed in Others Figure 21. Global Sorafenib Tosylate Tablets Market: Others (2016-2021) & (K Units) Figure 22. Global Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2021) Figure 23. Global Sorafenib Tosylate Tablets Revenue Market Share by Application in 2020 Figure 24. Sorafenib Tosylate Tablets Revenue Market by Company in 2020 ($ Million) Figure 25. Global Sorafenib Tosylate Tablets Revenue Market Share by Company in 2020 Figure 26. Global Sorafenib Tosylate Tablets Sales Market Share by Regions (2016-2021) Figure 27. Global Sorafenib Tosylate Tablets Revenue Market Share by Region in 2020 Figure 28. Americas Sorafenib Tosylate Tablets Sales 2016-2021 (K Units) Figure 29. Americas Sorafenib Tosylate Tablets Revenue 2016-2021 ($ Millions) Figure 30. APAC Sorafenib Tosylate Tablets Sales 2016-2021 (K Units) Figure 31. APAC Sorafenib Tosylate Tablets Revenue 2016-2021 ($ Millions) Figure 32. Europe Sorafenib Tosylate Tablets Sales 2016-2021 (K Units) Figure 33. Europe Sorafenib Tosylate Tablets Revenue 2016-2021 ($ Millions) Figure 34. Middle East & Africa Sorafenib Tosylate Tablets Sales 2016-2021 (K Units) Figure 35. Middle East & Africa Sorafenib Tosylate Tablets Revenue 2016-2021 ($ Millions) Figure 36. Americas Sorafenib Tosylate Tablets Sales Market Share by Country in 2020 Figure 37. Americas Sorafenib Tosylate Tablets Revenue Market Share by Country in 2020 Figure 38. Americas Sorafenib Tosylate Tablets Sales Market Share by Type in 2020 Figure 39. Americas Sorafenib Tosylate Tablets Sales Market Share by Application in 2020 Figure 40. United States Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 41. Canada Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 42. Mexico Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 43. Brazil Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 44. APAC Sorafenib Tosylate Tablets Sales Market Share by Region in 2020 Figure 45. APAC Sorafenib Tosylate Tablets Revenue Market Share by Regions in 2020 Figure 46. APAC Sorafenib Tosylate Tablets Sales Market Share by Type in 2020 Figure 47. APAC Sorafenib Tosylate Tablets Sales Market Share by Application in 2020 Figure 48. China Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 49. Japan Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 50. Korea Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 51. Southeast Asia Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 52. India Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 53. Australia Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 54. Europe Sorafenib Tosylate Tablets Sales Market Share by Country in 2020 Figure 55. Europe Sorafenib Tosylate Tablets Revenue Market Share by Country in 2020 Figure 56. Europe Sorafenib Tosylate Tablets Sales Market Share by Type in 2020 Figure 57. Europe Sorafenib Tosylate Tablets Sales Market Share by Application in 2020 Figure 58. Germany Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 59. France Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 60. UK Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 61. Italy Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 62. Russia Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 63. Middle East & Africa Sorafenib Tosylate Tablets Sales Market Share by Country in 2020 Figure 64. Middle East & Africa Sorafenib Tosylate Tablets Revenue Market Share by Country in 2020 Figure 65. Middle East & Africa Sorafenib Tosylate Tablets Sales Market Share by Type in 2020 Figure 66. Middle East & Africa Sorafenib Tosylate Tablets Sales Market Share by Application in 2020 Figure 67. Egypt Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 68. South Africa Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 69. Israel Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 70. Turkey Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 71. GCC Country Sorafenib Tosylate Tablets Revenue Growth 2016-2021 ($ Millions) Figure 72. Channels of Distribution Figure 73. Distributors Profiles |
| ※본 조사보고서 [세계의 소라페닙 토실레이트 정제 시장예측 2021년-2026년] (코드 : LPI-2201K02189) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 소라페닙 토실레이트 정제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |